Pall Corp. acquires Euroflow
Pall Corp. acquired Euroflow (UK), a leading manufacturer of pilot and production scale chromatography columns for the biotechnology industry. Pall held exclusive global marketing and distribution rights to Euroflow chromatography columns and associated technologies since 2002. Euroflow sales are currently about $5 million a year. 
Pall earlier acquired BioSepra Process Division of Ciphergen Biosystems Inc. BioSepra was strong in chromatography sorbents used in protein purification. These acquisitions now allow Pall to provide a complete fluid management system. Eric Krasnoff, chairman and CEO, Pall Corp., said, “We are responding to the industry's request for integrated systems solutions for purification technologies from development through large-scale production.â€? 

Thermo Electron to acquire Kendro 
In another development, Thermo Electron Corp. entered into a definitive agreement to acquire the Kendro Laboratory Products division of SPX Corp. for $833.5 million in cash, subject to a post-closing balance sheet adjustment. Kendro is a major supplier of laboratory equipment for sample preparation, processing and storage used primarily in life sciences and drug discovery laboratories and in clinical laboratories. 

PerkinElmer acquires Elcos AG
PerkinElmer Inc. has acquired Elcos AG, an European designer and manufacturer of custom LED (light emitting diode) solutions for biomedical and industrial applications. “Elcos has a successful track record of delivering high performance LED solutions with a majority of its revenues coming in from biomedical instrumentation,� said John Roush, president, PerkinElmer Optoelectronics.

Nasan Medicals launches PeriScope

Pune-based Nasan Medicals, in association with Hyderabad-based Genesis, developed a cardiovascular risk analysis system, PeriScope. According to YB Samant, director, Nasan Medicals PeriScope is a revolutionary, simple, economical and non-invasive screening and diagnostic tool that would pick up very early indications (even 5-8 years before) of diseases of the heart and blood vessels that cause heart attack, paralysis and kidney failure. "If detected early, such diseases can be prevented by simple medication or by mere a change in life style, saving one from high cost and high risk surgeries that need to be performed when it becomes an event like heart attack, kidney failure or paralysis," Samant said. PeriScope records ECG and blood pressure and presents it in the form of an actionable report giving the percentage heart, vascular and blockage risks through a simple painless test that takes less than 15 minutes, which does not even require a pre or post test preparation like fasting, injections or medication.
- Nanda Kasabe (CyberMedia News), Pune

Imperial ranked the best distributor of Stratagene

Chandigarh-based Imperial Bio-Medics has emerged as the "best distributor" of Stratagene worldwide for 2004. Over the last three years, Imperial grew Stratagene business by about 159 percent. "This was made possible by the team's indefatigable spirit to win," said Neeraj Gupta, corporate vice president, Imperial Bio-Medics. This growth in Stratagene's business encompasses all products categories-mutagenesis, RT PCR systems, cloning, PCR enzymes, libraries, nucleic acids analysis, etc. The company in 2003-04 registered an 80 percent growth, recording a turnover of Rs 10.2 crore.

Fabtech sets up new facility

Fabtech Technologies has set up a new facility at Umergaon in Gujarat. To start with, Fabtech will manufacture sterilizing tunnels. The first phase of the facility is nearing completion and is being a built over an area of 2000 sq meters. In the second phase, the facility will be further expanded to accommodate more equipment. "The plan is to make this facility fully independent and capable of delivering the full range of Fabtech equipment, "said K Aasif, director, Fabtech Technologies International Pvt Ltd.

Nasan Medicals launches PeriScope

Pune-based Nasan Medicals, in association with Hyderabad-based Genesis, developed a cardiovascular risk analysis system, PeriScope. According to YB Samant, director, Nasan Medicals PeriScope is a revolutionary, simple, economical and non-invasive screening and diagnostic tool that would pick up very early indications (even 5-8 years before) of diseases of the heart and blood vessels that cause heart attack, paralysis and kidney failure. "If detected early, such diseases can be prevented by simple medication or by mere a change in life style, saving one from high cost and high risk surgeries that need to be performed when it becomes an event like heart attack, kidney failure or paralysis," Samant said. PeriScope records ECG and blood pressure and presents it in the form of an actionable report giving the percentage heart, vascular and blockage risks through a simple painless test that takes less than 15 minutes, which does not even require a pre or post test preparation like fasting, injections or medication.
- Nanda Kasabe (CyberMedia News), Pune